Search results
What Is 'Ozempic Face'? Here's Everything You Need to Know About This Common Phenomenon
Parade· 4 days agoIt seems the pop culture and social media narrative surrounding Ozempic won't end. The anti-obesity...
This Is Why You’re Not Losing Weight on Semaglutide + Doctors’ Tips To Speed Results
Woman's World via Yahoo News· 5 days agoErogul. If you’re taking them at the same time, they’re making it harder for the semaglutide or any...
7 Benefits of Metformin (Including Weight Loss)
MediaFeed via AOL· 4 days agoMetformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for diabetes, you probably already...
Weight-Loss Drugs Boost Case for Pharma ETFs | ETF Trends
ETF Trends· 7 days agoWeight-loss drugs, including Ozempic, are reshaping consumer habits. With help from shares of some...
6 Weight Loss Supplements for Women
MediaFeed via AOL· 5 days agoFinding the best weight loss supplements for women (or anyone, really) can be like finding a needle in a haystack — except the needle might not actually...
Analyst unveils Amgen stock price target after weight-loss drug data
TheStreet via Yahoo Finance· 4 days agoMeanwhile, Novo Nordisk's (NVO) Wegovy reached $865 million in first-quarter sales. Ozempic, the...
Blockbuster weight loss drug Wegovy's sales just doubled — and could heat up even more with a price...
Business Insider· 4 days agoSales of Wegovy more than doubled in the first quarter year-on-year, to $1.3 billion.
Whip Your Gut Into Shape: Try These 12 Probiotic Foods to Boost Your Digestive Health
CNET· 7 days agoYou've probably heard of probiotics and how essential they are for a healthy gut and overall...
Launching an Obesity Medicine Practice? Key Considerations
Medscape· 4 days agoWith the demand for anti-obesity drugs continuing to soar and the provision of supportive care that...
Lilly Soars as Forecast Boost Shows Weight-Loss Drugs’ Power
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- Eli Lilly & Co.’s shares soared as its brighter outlook for 2024 raised the potential...